Psychiatric disorders such as anxiety, depression and addiction are often comorbid brain
pathologies thought to share common mechanistic biology. As part of the cortico-limbic …

J. Neurochem.(2011) 10.1111/j. 1471‐4159.2011. 07281. x Abstract As a ubiquitous
serine/threonine protein kinase, glycogen synthase kinase 3β (GSK‐3β) has been …

Understanding how ethanol actions on brain signal transduction and gene expression lead
to excessive consumption and addiction could identify new treatments for alcohol …

Glycogen synthase kinase 3β (GSK‐3β) is a ubiquitous serine/threonine protein kinase
involved in a number of signaling pathways. Previous studies have demonstrated a role for …

Although major depressive disorder (MDD) is highly prevalent, its pathophysiology is poorly
understood. Recent evidence suggests that glycogen-synthase kinase 3β (GSK3β) plays a …

There exists an immediate need to develop novel medications for the treatment of mood
disorders such as bipolar disorder and depression. Initial interest in glycogen synthase …

Emerging evidence has suggested that glycogen synthase kinase 3 (GSK-3) is a key
regulatory kinase involved in a plethora of processes in the nervous system, including …

Increasing evidence suggests that glycogen synthase kinase-3β (GSK-3β) plays a crucial
role in neurodegenerative/psychiatric disorders, while pan-neural knockout of GSK-3β also …

Glycogen synthase kinase 3 (GSK3) is a critical mediator of many intracellular signaling
systems. The activity of GSK3 is regulated by several kinases, with inactivation occurring via …

Glycogen synthase kinase 3β (GSK 3β), which is abundantly present in the brain, is known
to contribute to psychomotor stimulant‐induced locomotor behaviors. However, most studies …